N/A Completed N=1,205 Randomized Single-blind Health Services Research

Educational Intervention to Improve HPV Vaccination Decision Quality

HPV Vaccination Decision Quality

Source: ClinicalTrials.gov NCT02797054 ↗

Enrolled (actual)

1,205

Serious AEs

0.0%

Results posted

Aug 2018

Primary outcomePrimary: Percent of Participants - Who Agreed They Felt Sure About the Best Choice Regarding the HPV Vaccine at Post-intervention — 94; 95; 89 Percent of participants — p=0.069

Summary

The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The objectives/aims of this HPV educational intervention project are: 1. To measure the quality of the HPV vaccine decision among participants in different arms of the intervention 2. To determine patterns of intervention utilization among participants in different arms of the intervention, and The implementation of this educational intervention in clinic waiting rooms is intended to assist primary care providers in communicating HPV vaccine awareness and education to parents and patients in a culturally tailored format.

Outcome Measures

Outcome	Result	p-value
PRIMARY Percent of Participants - Who Agreed They Felt Sure About the Best Choice Regarding the HPV Vaccine at Post-intervention	94; 95; 89	0.069
PRIMARY Percent of Participants Who Agreed They Knew Enough About the Risks and Benefits of the HPV Vaccine at Post-intervention	75; 77; 69	0.303
PRIMARY Percent of Participants Who Agreed They Felt Clear About Which Risks and Benefits of the HPV Vaccine Mattered Most to Them at Post-intervention	85; 87; 71	0.001 sig
PRIMARY Percent of Participants Who Agreed They Felt They Had Enough Support to Make a Decision About Getting the HPV Vaccine at Post-intervention	86; 87; 86	0.895
PRIMARY Percent of Participants Who Agreed They Felt Sure About the Best Choice Regarding the HPV Vaccine at Follow-up	96; 95; 94	0.58
PRIMARY Percent of Participants Who Agreed They Knew Enough About the Risks and Benefits of the HPV Vaccine at Follow-up	76; 73; 60	0.0015 sig
PRIMARY Percent of Participants Who Agreed They Felt Clear About Which Risks and Benefits of the HPV Vaccine Mattered Most to Them at Follow-up	78; 78; 65	0.0056 sig
PRIMARY Percent of Participants Who Agreed They Felt They Had Enough Support to Make a Decision About Getting the HPV Vaccine at Follow-up	85; 84; 77	0.21

Eligibility Criteria

Inclusion Criteria

Parents of an adolescent between the ages of 9-17
A young adult patient between the ages of 18-26
Adolescent/young adult who has not yet received all three doses of the HPV vaccine.
Parent/young adult who can read and converse in either English or Spanish

Exclusion Criteria

Age <18,
Prisoners
Decisionally challenged subjects
Those who cannot read and converse in either English or Spanish
Those who have received all 3 doses of the HPV vaccine

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02797054). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.